MeiraGTx Holdings PLC Sustainability Reports

MeiraGTx Holdings PLC is a clinical-stage genetic medicines company developing targeted gene therapies for diseases with high unmet need. The company focuses on disorders affecting the eye, central nervous system, and salivary glands, supported by in-house manufacturing capabilities.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 54930007YV6NYIOGFZ57

FIGI: BBG00KXH4D62

No reports are currently available in our catalogue.